These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 919379)

  • 1. [Catecholamine storage in schizophrenia].
    Baru AM; Mys'ko GN
    Vopr Med Khim; 1977; 23(4):550-4. PubMed ID: 919379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Several indices of the methylation process in schizophrenic patients].
    Mys'ko GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(7):1058-62. PubMed ID: 19907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Dulay JR; Weis S
    Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
    Webster MJ; O'Grady J; Kleinman JE; Weickert CS
    Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of prostaglandins and prolactin in depression, mania and schizophrenia.
    Horrobin DF
    Postgrad Med J; 1977; 53 Suppl 4():160-5. PubMed ID: 341105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biosynthesis of biogenic pyrimidines in anxiety and depressive states of different etiologies].
    Karkishchenko NN; Stradomskiĭ BV; Makliakov IuS; Zaika VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):73-4. PubMed ID: 1650103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for a noradrenaline hypothesis of schizophrenia.
    Yamamoto K; Hornykiewicz O
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):913-22. PubMed ID: 15363614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
    Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
    Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemistry of psychosis.
    Antun F
    J Med Liban; 1973; 26(6):615-25. PubMed ID: 4593351
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonadal hormones in schizophrenia and mood disorders.
    Ozcan ME; Banoglu R
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):193-6. PubMed ID: 12910350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the processes of lipid peroxidation in patients with endogenous psychoses using gas chromatography].
    Kovaleva ES; Orlov ON; Bogdanova ED; Beliaev BS; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):99-103. PubMed ID: 2718675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased noradrenaline levels in CSF and plasma of schizophrenic patients.
    Kemali D; Del Vecchio M; Maj M
    Biol Psychiatry; 1982 Jun; 17(6):711-7. PubMed ID: 7104421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
    Kuloglu M; Ustundag B; Atmaca M; Canatan H; Tezcan AE; Cinkilinc N
    Cell Biochem Funct; 2002 Jun; 20(2):171-5. PubMed ID: 11979513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mental health and primary care services by caregivers of patients with bipolar disorder: a preliminary study.
    Perlick DA; Hohenstein JM; Clarkin JF; Kaczynski R; Rosenheck RA
    Bipolar Disord; 2005 Apr; 7(2):126-35. PubMed ID: 15762853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
    Digney A; Keriakous D; Scarr E; Thomas E; Dean B
    Biol Psychiatry; 2005 Apr; 57(7):711-5. PubMed ID: 15820227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members.
    Gianfrancesco FD; Wang RH; Yu E
    Soc Sci Med; 2005 Jul; 61(2):305-11. PubMed ID: 15893047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.
    Ubhi K; Price J
    BMC Psychiatry; 2005 Oct; 5():38. PubMed ID: 16246257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
    Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.